These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37644759)

  • 1. Phospholipid headgroup composition modulates the molecular interactions and antimicrobial effects of sulfobetaine zwitterionic detergents against the "ESKAPE" pathogen
    Hilton KLF; Tolley H; Ortega-Roldan JL; Thompson GS; Sutton JM; Hind CK; Hiscock JR
    Chem Commun (Camb); 2023 Aug; 59(70):10504-10507. PubMed ID: 37644759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phospholipase B from Pseudomonas aeruginosa with activity towards endogenous phospholipids affects biofilm assembly.
    Weiler AJ; Spitz O; Gudzuhn M; Schott-Verdugo SN; Kamel M; Thiele B; Streit WR; Kedrov A; Schmitt L; Gohlke H; Kovacic F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Apr; 1867(4):159101. PubMed ID: 35063652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the permeability of Pseudomonas aeruginosa cell walls toward lipophilic compounds: effects of ultrasound and cell age.
    Rapoport N; Smirnov AI; Timoshin A; Pratt AM; Pitt WG
    Arch Biochem Biophys; 1997 Aug; 344(1):114-24. PubMed ID: 9244388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific phospholipids enhance the activity of beta-lactam antibiotics against Pseudomonas aeruginosa.
    Krogfelt KA; Utley M; Krivan HC; Laux DC; Cohen PS
    J Antimicrob Chemother; 2000 Sep; 46(3):377-84. PubMed ID: 10980163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the effect of detergents on the full-length rhomboid protease from Pseudomonas aeruginosa and its cytosolic domain.
    Sherratt AR; Braganza MV; Nguyen E; Ducat T; Goto NK
    Biochim Biophys Acta; 2009 Nov; 1788(11):2444-53. PubMed ID: 19761755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and phenotypes associated with virulence.
    Baker LY; Hobby CR; Siv AW; Bible WC; Glennon MS; Anderson DM; Symes SJ; Giles DK
    BMC Microbiol; 2018 Sep; 18(1):117. PubMed ID: 30217149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Activity of, and Cellular Pathways Targeted by,
    Adewunmi Y; Namjilsuren S; Walker WD; Amato DN; Amato DV; Mavrodi OV; Patton DL; Mavrodi DV
    Appl Environ Microbiol; 2020 Feb; 86(4):. PubMed ID: 31811038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two-dimensional electrophoresis.
    Luche S; Santoni V; Rabilloud T
    Proteomics; 2003 Mar; 3(3):249-53. PubMed ID: 12627377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa strain PAO to dyes, detergents, and antibiotics.
    Kropinski AM; Chan L; Milazzo FH
    Antimicrob Agents Chemother; 1978 Mar; 13(3):494-9. PubMed ID: 122525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Silkworm Cecropin B Antimicrobial Activity against
    Romoli O; Mukherjee S; Mohid SA; Dutta A; Montali A; Franzolin E; Brady D; Zito F; Bergantino E; Rampazzo C; Tettamanti G; Bhunia A; Sandrelli F
    ACS Infect Dis; 2019 Jul; 5(7):1200-1213. PubMed ID: 31045339
    [No Abstract]   [Full Text] [Related]  

  • 11. Potent effects of amino acid scanned antimicrobial peptide Feleucin-K3 analogs against both multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.
    Xie J; Li Y; Li J; Yan Z; Wang D; Guo X; Zhang J; Zhang B; Mou L; Yang W; Jiang X
    Amino Acids; 2018 Oct; 50(10):1471-1483. PubMed ID: 30136030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CmpX Affects Virulence in Pseudomonas aeruginosa Through the Gac/Rsm Signaling Pathway and by Modulating c-di-GMP Levels.
    Bhagirath AY; Somayajula D; Li Y; Duan K
    J Membr Biol; 2018 Feb; 251(1):35-49. PubMed ID: 29063141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
    Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
    Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural investigation of sulfobetaines and phospholipid monolayers at the air-water interface.
    Elstone N; Arnold T; Skoda MWA; Lewis SE; Li P; Hazell G; Edler KJ
    Phys Chem Chem Phys; 2022 Sep; 24(37):22679-22690. PubMed ID: 36106535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of
    Ocampo-Ibáñez ID; Liscano Y; Rivera-Sánchez SP; Oñate-Garzón J; Lugo-Guevara AD; Flórez-Elvira LJ; Lesmes MC
    Evol Bioinform Online; 2020; 16():1176934320936266. PubMed ID: 32636607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
    Patil A; Banerji R; Kanojiya P; Saroj SD
    Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane phospholipid composition of Pseudomonas aeruginosa grown in a cystic fibrosis mucus-mimicking medium.
    Deschamps E; Schaumann A; Schmitz-Afonso I; Afonso C; Dé E; Loutelier-Bourhis C; Alexandre S
    Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183482. PubMed ID: 33002450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic investigations of the binding mechanisms between antimicrobial peptides and membrane models of Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Chai H; Allen WE; Hicks RP
    Bioorg Med Chem; 2014 Aug; 22(15):4210-22. PubMed ID: 24931276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
    Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.